In the ATTAIN-2 trial, participants lost an average of 22.9 lbs (10.5 percent) on the highest (36mg) dose of orforglipron, with A1C reduced by an average of 1.8 percent
Conversely, oral formulations clear more rapidly, typically requiring only a 24-hour pause before most procedures
This work was supported by the Funds of the National Natural Science Foundation of China (82060728), the Guizhou Provincial Science and Technology Department (MS [2025-380], Thousand Talents Program), the Talents of Guizhou Science and Technology Platform [2021]1350-009, the Zunyi Science and Technology Bureau (HZ-2023-173, HZ-2023-09, [2024] No
Finally, sections were mounted with anti-fluorescence quenching mounting medium (with DAPI) (Solarbio) and imaged using microscope with consistent laser power and gain settings across samples